- Nordic Nanovector Awarded NOK 12 Million in Funding From the Norwegian Research Council to Advance Alpha37, a Targeted Alpha Therapy for B-cell Cancers
- Nordic Nanovector Provides Update on LYMRIT 37-05 Phase 1 DLBCL Trial
- Nordic Nanovector ASA: Allocation of PSUs
- Nordic Nanovector: New preclinical Data Offer Insights Into Enhancing Betalutin®-Based Therapies in NHL
- Nordic Nanovector ASA - Financial Calendar
- Nordic Nanovector ASA - Results for the Third Quarter 2019
- Nordic Nanovector to Participate in Four Upcoming Investor Conferences
- Nordic Nanovector ASA: Invitation to Third Quarter 2019 Results Presentation and Webcast
As of last trade,
Nordic Nanovector ASA (8NN:DEU) traded at 2.59, 33.44% above the 52 week low of 1.94 set on Oct 24, 2019.
1.94Oct 24 20195.17Jan 23 2019
Markit short selling activity
|Market cap||1.57bn NOK|
|EPS (TTM)||-7.23 |
Data delayed at least 15 minutes, as of Jan 23 2020 13:29 GMT.